CD8A and triple-negative breast carcinoma: Another intestinal metabolite, Trimetlylamine-N-oxide (TMAO), which is produced from a choline-rich diet by certain gut microbes, enhanced the ICI activity in triple-negative breast cancer by inducing pyroptosis in tumor cells and elevating CD8+ T cell-mediated anti-tumor immunity [38].